The neurobiological pathogenesis of poststroke depression

The Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Feng, Chao ^a   Fang, Min ^b   Liu, Xue Yuan ^b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOLAMINE; CITALOPRAM; CYTOKINE; DOPAMINE; GLUCOCORTICOID; GLUTAMIC ACID; HYDROCORTISONE; MONOAMINE; NEUROTRANSMITTER; NEUROTROPHIN; NORADRENALIN; SEROTONIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

BASAL GANGLION; BRAIN DAMAGE; BRAIN FUNCTION; BRAIN INFARCTION SIZE; CELL DEATH; CEREBROVASCULAR ACCIDENT; DEPRESSION; EXCITOTOXICITY; FRONTAL LOBE; HIPPOCAMPUS; HUMAN; HYPERCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; INFLAMMATION; LATE LIFE DEPRESSION; NERVOUS SYSTEM DEVELOPMENT; NEUROANATOMY; NEUROBIOLOGY; NEUROTRANSMISSION; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; POSTSTROKE DEPRESSION; PREVALENCE; PSYCHOLOGICAL ASPECT; REVIEW; STRESS; COMPLICATION; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY;

DEPRESSION; GLUCOCORTICOIDS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNE SYSTEM; NEUROTRANSMITTER AGENTS; PITUITARY-ADRENAL SYSTEM; STROKE;

EID: 84898892273     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/521349     Document Type: Review

References (101)

1. Dafer R. M., Rao M., Shareef A., Sharma A., Poststroke depression. Topics in Stroke Rehabilitation 2008 15 1 13 21 2-s2.0-38549109617 10.1310/tsr1501-13
2. Loubinoux I., Kronenberg G., Endres M., Schumann-Bard P., Freret T., Filipkowski R. K., Kaczmarek L., Popa-Wagner A., Post-stroke depression: mechanisms, translation and therapy. Journal of Cellular and Molecular Medicine 2012 16 9 1961 1969 10.1111/j.1582-4934.2012.01555.x
3. Quaranta D., Marra C., Gainotti G., Post-stroke depression: main phenomenological clusters and their relationships with clinical measures. Behavioural Neurology 2012 25 4 303 310 10.1155/2012/501979
4. Robinson R. G., Shoemaker W. J., Schlumpf M., Effect of experimental cerebral infarction in rat brain on catecholamines and behaviour. Nature 1975 255 5506 332 334 2-s2.0-0016680525
5. Robinson R. G., Kubos K. L., Starr L. B., Mood changes in stroke patients: relationship to lesion location. Comprehensive Psychiatry 1983 24 6 555 566 2-s2.0-0021068361
6. Beblo T., Wallesch C., Herrmann M., The crucial role of frontostriatal circuits for depressive disorders in the postacute stage after stroke. Neuropsychiatry, Neuropsychology and Behavioral Neurology 1999 12 4 236 246 2-s2.0-0032739244
7. Santos M., Kövari E., Gold G., Bozikas V. P., Hof P. R., Bouras C., Giannakopoulos P., The neuroanatomical model of post-stroke depression: towards a change of focus? Journal of the Neurological Sciences 2009 283 1-2 158 162 2-s2.0-67650475912 10.1016/j.jns.2009.02.334
8. Drevets W. C., Price J. L., Furey M. L., Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Structure and Function 2008 213 1-2 93 118 2-s2.0-50249084453 10.1007/s00429-008-0189-x
9. Tang W. K., Lu J. Y., Chen Y. K., Chu W. C. W., Mok V., Ungvari G. S., Wong K. S., Association of frontal subcortical circuits infarcts in poststroke depression: a magnetic resonance imaging study of 591 Chinese patients with ischemic stroke. Journal of Geriatric Psychiatry and Neurology 2011 24 1 44 49 2-s2.0-79951897627 10.1177/0891988710392375
10. Vataja R., Pohjasvaara T., Leppavuori A., Mantyla R., Aronen H. J., Salonen O., Kaste M., Erkinjuntti T., Magnetic resonance imaging correlates of depression after ischemic stroke. Archives of General Psychiatry 2001 58 10 925 931 10.1001/archpsyc.58.10.925
11. Terroni L., Amaro E. Jr., Iosifescu D. V., Tinone G., Sato J. R., Leite C. C., Sobreiro M. F. M., Lucia M. C. S., Scaff M., Fráguas R., Stroke lesion in cortical neural circuits and post-stroke incidence of major depressive episode: a 4-month prospective study. World Journal of Biological Psychiatry 2011 12 7 539 548 2-s2.0-80054863895 10.3109/15622975.2011.562242
12. Kronenberg G., Balkaya M., Prinz V., Gertz K., Ji S., Kirste I., Heuser I., Kampmann B., Hellmann-Regen J., Gass P., Sohr R., Hellweg R., Waeber C., Juckel G., Hörtnagl H., Stumm R., Endres M., Exofocal dopaminergic degeneration as antidepressant target in mouse model of poststroke depression. Biological Psychiatry 2012 72 4 273 281 2-s2.0-84858977329 10.1016/j.biopsych. 2012.02.026
13. Dam H., Pedersen H. E., Ahlgren P., Depression among patients with stroke. Acta Psychiatrica Scandinavica 1989 80 2 118 124 2-s2.0-0024434225
14. MacHale S. M., O'Rourke S. J., Wardlaw J. M., Dennis M. S., Depression and its relation to lesion location after stroke. Journal of Neurology Neurosurgery and Psychiatry 1998 64 3 371 374 2-s2.0-0031953694
15. Wang Y., Zhang T., Jing X., Zhao X., Wang C., Liu Z., Zhou Y., Wang Y., A prospective cohort study of lesion location and its relation to post-stroke depression among Chinese patients. Journal of Affective Disorders 2012 136 1-2 e83 e87 2-s2.0-84857062243 10.1016/j.jad.2011.06.014
16. Caeiro L., Ferro J. M., Santos C. O., Figueira M. L., Depression in acute stroke. Journal of Psychiatry and Neuroscience 2006 31 6 377 383 2-s2.0-33751330004
17. Aben I., Lodder J., Honig A., Lousberg R., Boreas A., Verhey F., Focal or generalized vascular brain damage and vulnerability to depression after stroke: a 1-year prospective follow-up study. International Psychogeriatrics 2006 18 1 19 35 2-s2.0-33645675536 10.1017/S104161020500270X
18. Snaphaan L., van der Werf S., Kanselaar K., de Leeuw F., Post-stroke depressive symptoms are associated with post-stroke characteristics. Cerebrovascular Diseases 2009 28 6 551 557 2-s2.0-70350050762 10.1159/000247598
19. Carson A. J., MacHale S., Allen K., Lawrie S. M., Dennis M., House A., Sharpe M., Depression after stroke and lesion location: a systematic review. The Lancet 2000 356 9224 122 126 2-s2.0-0034622274
20. Yu L., Liu C., Chen J., Wang S., Wu Y., Yu S., Relationship between post-stroke depression and lesion location: a meta-analysis. Kaohsiung Journal of Medical Sciences 2004 20 8 372 380 2-s2.0-4644239246
21. Bhogal S. K., Teasell R., Foley N., Speechley M., Lesion location and poststroke depression: systematic review of the methodological limitations in the literature. Stroke 2004 35 3 794 802 2-s2.0-1442274758 10.1161/01.STR. 0000117237.98749.26
22. Vataja R., Leppävuori A., Pohjasvaara T., Mäntylä R., Aronen H. J., Salonen O., Kaste M., Erkinjuntti T., Poststroke depression and lesion location revisited. Journal of Neuropsychiatry and Clinical Neurosciences 2004 16 2 156 162 2-s2.0-2342419710 10.1176/appi.neuropsych.16.2.156
23. Nys G. M. S., van Zandvoort M. J. E., van der Worp H. B., de Haan E. H. F., de Kort P. L. M., Kappelle L. J., Early depressive symptoms after stroke: neuropsychological correlates and lesion characteristics. Journal of the Neurological Sciences 2005 228 1 27 33 2-s2.0-10644269280 10.1016/j.jns.2004.09. 031
24. Hickie I., Scott E., Mitchell P., Wilhelm K., Austin M., Bennett B., Subcortical hyperintensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biological Psychiatry 1995 37 3 151 160 2-s2.0-0028832032 10.1016/0006-3223(94)00174-2
25. Salloway S., Malloy P., Kohn R., Gillard E., Duffy J., Rogg J., Tung G., Richardson E., Thomas C., Westlake R., MRI and neuropsychological differences in early- and late-life-onset geriatric depression. Neurology 1996 46 6 1567 1574 2-s2.0-8944262350
26. Fujikawa T., Yamawaki S., Touhouda Y., Incidence of silent cerebral infarction in patients with major depression. Stroke 1993 24 11 1631 1634 2-s2.0-0027435361
27. Krishnan K. R. R., Hays J. C., Blazer D. G., MRI-defined vascular depression. American Journal of Psychiatry 1997 154 4 497 501 2-s2.0-0030952372
28. Alexopoulos G. S., Meyers B. S., Young R. C., Campbell S., Silbersweig D., Charlson M., 'Vascular depression" hypothesis. Archives of General Psychiatry 1997 54 10 915 922 2-s2.0-0031451874
29. Alexopoulos G. S., The vascular depression hypothesis: 10 years later. Biological Psychiatry 2006 60 12 1304 1305 2-s2.0-33751546364 10.1016/j.biopsych.2006.09.006
30. Sneed J. R., Culang-Reinlieb M. E., The vascular depression hypothesis: an update. American Journal of Geriatric Psychiatry 2011 19 2 99 103 2-s2.0-79551474872 10.1097/JGP.0b013e318202fc8a
31. Herrmann L. L., Le Masurier M., Ebmeier K. P., White matter hyperintensities in late life depression: a systematic review. Journal of Neurology, Neurosurgery and Psychiatry 2008 79 6 619 624 2-s2.0-44449172008 10.1136/jnnp.2007.124651
32. Aizenstein H. J., Andreescu C., Edelman K. L., Cochran J. L., Price J., Butters M. A., Karp J., Patel M., Reynolds C. F. III, fMRI correlates of white matter hyperintensities in late-life depression. American Journal of Psychiatry 2011 168 10 1075 1082 2-s2.0-80054827880 10.1176/appi.ajp.2011.10060853
33. Vasudev A., Saxby B. K., OBrien J. T., Colloby S. J., Firbank M. J., Brooker H., Wesnes K., Thomas A. J., Relationship between cognition, magnetic resonance white matter hyperintensities, and cardiovascular autonomic changes in late-life depression. American Journal of Geriatric Psychiatry 2012 20 8 691 699 10.1097/JGP.0b013e31824c0435
34. Grool A. M., van der Graaf Y., Mali W. P. T. M., WitkampTh.D. W. D., Vincken K. L., Geerlings M. I., Location and progression of cerebral small-vessel disease and atrophy, and depressive symptom profiles: the Second Manifestations of ARTerial disease (SMART)-Medea study. Psychological Medicine 2012 42 2 359 370 2-s2.0-84857367762 10.1017/S0033291711001383
35. Sheline Y. I., Pieper C. F., Barch D. M., Welsh-Boehmer K., McKinstry R. C., MacFall J. R., D'Angelo G., Garcia K. S., Gersing K., Wilkins C., Taylor W., Steffens D. C., Krishnan R. R., Doraiswamy P. M., Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. Archives of General Psychiatry 2010 67 3 277 285 2-s2.0-77649200235 10.1001/archgenpsychiatry.2009.204
36. Alexopoulos G. S., Bruce M. L., Silbersweig D., Kalayam B., Stern E., Vascular depression: a new view of late-onset depression. Dialogues in Clinical Neuroscience 1999 1 2 68 80
37. Brodaty H., Withall A., Altendorf A., Sachdev P. S., Rates of depression at 3 and 15 months poststroke and their relationship with cognitive decline: the Sydney Stroke study. American Journal of Geriatric Psychiatry 2007 15 6 477 486 2-s2.0-34547660416 10.1097/JGP.0b013e3180590bca
38. Kim J., Park M., Yoon G., Jung H., Choi K., Nam T., Lee S., Choi S., Kim B., Kim M., Cho K., White matter hyperintensity as a factor associated with delayed mood disorders in patients with acute ischemic stroke. European Neurology 2011 66 6 343 349 2-s2.0-81155144623 10.1159/000332585
39. Santos M., Gold G., Kövari E., Herrmann F. R., Bozikas V. P., Bouras C., Giannakopoulos P., Differential impact of lacunes and microvascular lesions on poststroke depression. Stroke 2009 40 11 3557 3562 2-s2.0-70350560777 10.1161/STROKEAHA.109.548545
40. Tennen G., Herrmann N., Black S. E., Levy K. S., Cappell J., Li A., Lanctôt K. L., Are vascular risk factors associated with post-stroke depressive symptoms? Journal of Geriatric Psychiatry and Neurology 2011 24 4 215 221 2-s2.0-84855464397 10.1177/0891988711422526
41. Pascoe M. C., Crewther S. G., Carey L. M., Noonan K., Crewther D. P., Linden T., Homocysteine as a potential biochemical marker for depression in elderly stroke survivors. Food & Nutrition Research 2012 56 14973 10.3402/fnr.v56i0.14973
42. Santos M., Kövari E., Hof P. R., Gold G., Bouras C., Giannakopoulos P., The impact of vascular burden on late-life depression. Brain Research Reviews 2009 62 1 19 32 2-s2.0-70449624835 10.1016/j.brainresrev.2009.08.003
43. Mast B. T., MacNeill S. E., Lichtenberg P. A., Post-stroke and clinically-defined vascular depression in geriatric rehabilitation patients. American Journal of Geriatric Psychiatry 2004 12 1 84 92 2-s2.0-0347192996 10.1176/appi.ajgp.12.1.84
44. Parker G., Brotchie H., Mood effects of the amino acids tryptophan and tyrosine: "Food for Thought'. Acta Psychiatrica Scandinavica 2011 124 6 417 426 2-s2.0-81255141914 10.1111/j.1600-0447.2011.01706.x
45. Robinson R. G., Bloom F. E., Pharmacological treatment following experimental cerebral infarction: implications for understanding psychological symptoms of human stroke. Biological Psychiatry 1977 12 5 669 680 2-s2.0-0017739370
46. Gao H., Zhu H., Zhang Y., Wang L., Reduction of cerebrospinal fluid and plasma serotonin in patients with post-stroke depression: a preliminary report. Clinical and Investigative Medicine 2008 31 6 E351 E356 2-s2.0-57049131070
47. Winter C., von Rumohr A., Mundt A., Petrus D., Klein J., Lee T., Morgenstern R., Kupsch A., Juckel G., Lesions of dopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior in rats. Behavioural Brain Research 2007 184 2 133 141 2-s2.0-34848892098 10.1016/j.bbr.2007.07.002
48. Wang S., Zhang Z., Guo Y., Teng G., Chen B., Decreased expression of serotonin 1A receptor in the dentate gyrus in association with chronic mild stress: a rat model of post-stroke depression. Psychiatry Research 2009 170 2-3 245 251 2-s2.0-70449553410 10.1016/j.psychres.2008.07.006
49. Cravello L., Caltagirone C., Spalletta G., The SNRI venlafaxine improves emotional unawareness in patients with post-stroke depression. Human Psychopharmacology 2009 24 4 331 336 2-s2.0-68049131293 10.1002/hup.1021
50. Kimura M., Kanetani K., Imai R., Suzuki H., Isayama K., Endo S., Therapeutic effects of milnacipran, a serotonin and noradrenaline reuptake inhibitor, on post-stroke depression. International Clinical Psychopharmacology 2002 17 3 121 125 2-s2.0-0036238117
51. Hashimoto K., Emerging role of glutamate in the pathophysiology of major depressive disorder. Brain Research Reviews 2009 61 2 105 123 2-s2.0-70349513258 10.1016/j.brainresrev.2009.05.005
52. Niciu M. J., Kelmendi B., Sanacora G., Overview of glutamatergic neurotransmission in the nervous system. Pharmacology Biochemistry and Behavior 2012 100 4 656 664 2-s2.0-84855549573 10.1016/j.pbb.2011.08.008
53. McCarthy D. J., Alexander R., Smith M. A., Pathak S., Kanes S., Lee C., Sanacora G., Glutamate-based depression GBD. Medical Hypotheses 2012 78 5 675 681 2-s2.0-84859267636 10.1016/j.mehy.2012.02.009
54. Musazzi L., Milanese M., Farisello P., Zappettini S., Tardito D., Barbiero V. S., Bonifacino T., Mallei A., Baldelli P., Racagni G., Raiteri M., Benfenati F., Bonanno G., Popoli M., Acute stress increases depolarization- evoked glutamate release in the rat prefrontal/frontal cortex: the dampening action of antidepressants. PLoS ONE 2010 5 1 2-s2.0-77649124734 10.1371/journal.pone.0008566 e8566
55. Glodzik-Sobanska L., Slowik A., McHugh P., Sobiecka B., Kozub J., Rich K. E., Urbanik A., Szczudlik A., Single voxel proton magnetic resonance spectroscopy in post-stroke depression. Psychiatry Research 2006 148 2-3 111 120 2-s2.0-33750974176 10.1016/j.pscychresns.2006.08.004
56. Wang X., Li Y. H., Li M. H., Lu J., Zhao J. G., Sun X. J., Zhang B., Ye J. L., Glutamate level detection by magnetic resonance spectroscopy in patients with post-stroke depression. European Archives of Psychiatry and Clinical Neuroscience 2012 262 1 33 38 10.1007/s00406-011-0209-3
57. Iadecola C., Anrather J., The immunology of stroke: from mechanisms to translation. Nature Medicine 2011 17 7 796 808 2-s2.0-79960141471 10.1038/nm.2399
58. Müller N., Myint A., Schwarz M. J., Inflammatory biomarkers and depression. Neurotoxicity Research 2011 19 2 308 318 2-s2.0-79751511547 10.1007/s12640-010-9210-2
59. Li M., Soczynska J. K., Kennedy S. H., Inflammatory biomarkers in depression: an opportunity for novel therapeutic interventions. Current Psychiatry Reports 2011 13 5 316 320 2-s2.0-80755153592 10.1007/s11920-011-0210- 6
60. Leonard B. E., The concept of depression as a dysfunction of the immune system. Current Immunology Reviews 2010 6 3 205 212 2-s2.0-77958068373 10.2174/157339510791823835
61. Maes M., The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. Neuroendocrinology Letters 2008 29 3 287 291 2-s2.0-48049084135
62. Pascoe M. C., Crewther S. G., Carey L. M., Crewther D. P., Inflammation and depression: why poststroke depression may be the norm and not the exception. International Journal of Stroke 2011 6 2 128 135 2-s2.0-79952303451 10.1111/j.1747-4949.2010.00565.x
63. Saito K., Suyama K., Nishida K., Sei Y., Basile A. S., Early increases in TNF- IL-6 and IL-1 β levels following transient cerebral ischemia in gerbil brain. Neuroscience Letters 1996 206 2-3 149 152 2-s2.0-0029670016 10.1016/S0304-3940(96)12460-5
64. Yamasaki Y., Matsuura N., Shozuhara H., Onodera H., Itoyama Y., Kogure K., Schmid-Schonbein G. W., Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 1995 26 4 676 681 2-s2.0-0028958354
65. Caso J. R., Lizasoain I., Lorenzo P., Moro M. A., Leza J. C., The role of tumor necrosis factor-alpha in stress-induced worsening of cerebral ischemia in rats. Neuroscience 2006 142 1 59 69 2-s2.0-33748465894 10.1016/j.neuroscience. 2006.06.009
66. Fan T., Jiang W. L., Zhu J., Zhang Y. F., Arctigenin protects focal cerebral ischemia-reperfusion rats through inhibiting neuroinflammation. Biological and Pharmaceutical Bulletin 2012 35 11 2004 2009
67. Domaç F. M., Somay G., Misirli H., Erenoglu N. Y., Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke. Neurosciences 2007 12 1 25 30 2-s2.0-34250020492
68. Wang S., Yuan Y., Xia W., Li F., Huang Y., Zhou Y., Guo Y., Neuronal apoptosis and synaptic density in the dentate gyrus of ischemic rats' response to chronic mild stress and the effects of notch signaling. PLoS ONE 2012 7 8 e42828 10.1371/journal.pone.0042828
69. Semmler A., Okulla T., Sastre M., Dumitrescu-Ozimek L., Heneka M. T., Systemic inflammation induces apoptosis with variable vulnerability of different brain regions. Journal of Chemical Neuroanatomy 2005 30 2-3 144 157 2-s2.0-25144435958 10.1016/j.jchemneu.2005.07.003
70. Kubera M., Obuchowicz E., Goehler L., Brzeszcz J., Maes M., In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011 35 3 744 759 2-s2.0-79954621673 10.1016/j.pnpbp.2010.08.026
71. Kosten T. A., Galloway M. P., Duman R. S., Russell D. S., D'Sa C., Repeated unpredictable stress and antidepressants differentially regulate expression of the Bcl-2 family of apoptotic genes in rat cortical, hippocampal, and limbic brain structures. Neuropsychopharmacology 2008 33 7 1545 1558 2-s2.0-43649084022 10.1038/sj.npp.1301527
72. Tobe I., Ishida Y., Tanaka M., Endoh H., Fujioka T., Nakamura S., Effects of repeated maternal stress on Fos expression in the hypothalamic paraventricular nucleus of fetal rats. Neuroscience 2005 134 2 387 395 2-s2.0-23444460266 10.1016/j.neuroscience.2005.04.023
73. Anderson C. M., Swanson R. A., Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 2000 32 1 1 14
74. Miller A. H., Maletic V., Raison C. L., Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biological Psychiatry 2009 65 9 732 741 2-s2.0-63449122724 10.1016/j.biopsych.2008.11.029
75. Miller A. H., Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface. Brain, Behavior, and Immunity 2009 23 2 149 158 2-s2.0-58549087919 10.1016/j.bbi.2008.08.006
76. Felger J. C., Alagbe O., Hu F., Mook D., Freeman A. A., Sanchez M. M., Kalin N. H., Ratti E., Nemeroff C. B., Miller A. H., Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression. Biological Psychiatry 2007 62 11 1324 1333 2-s2.0-35848935025 10.1016/j.biopsych.2007.05.026
77. Zhu C., Blakely R. D., Hewlett W. A., The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 2006 31 10 2121 2131 2-s2.0-33748808678 10.1038/sj.npp.1301029
78. Dantzer R., O'Connor J. C., Lawson M. A., Kelley K. W., Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology 2011 36 3 426 436 2-s2.0-79951960581 10.1016/j.psyneuen.2010.09.012
79. Mitchell A. J., Clinical implications of poststroke hypothalamo-pituitary adrenal axis dysfunction: a critical literature review. Journal of Stroke and Cerebrovascular Diseases 1997 6 6 377 388 2-s2.0-0001394628 10.1016/S1052- 3057(97)80038-9
80. Johansson Å., Olsson T., Carlberg B., Karlsson K., Fagerlund M., Hypercortisolism after stroke-partly cytokine-mediated? Journal of the Neurological Sciences 1997 147 1 43 47 2-s2.0-0031579662 10.1016/S0022-510X(96) 05308-7
81. Weidenfeld J., Leker R. R., Gai N., Teichner A., Bener D., Ovadia H., The function of the adrenocortical axis in permanent middle cerebral artery occlusion: effect of glucocorticoids on the neurological outcome. Brain Research 2011 1407 90 96 2-s2.0-79961005728 10.1016/j.brainres.2011.06.035
82. Astrom M., Olsson T., Asplund K., Different linkage of depression to hypercortisolism early versus late after stroke: a 3-year longitudinal study. Stroke 1993 24 1 52 57 2-s2.0-0027470795
83. Herbert J., Goodyer I. M., Grossman A. B., Hastings M. H., de Kloet E. R., Lightman S. L., Lupien S. J., Roozendaal B., Seckl J. R., Do corticosteroids damage the brain? Journal of Neuroendocrinology 2006 18 6 393 411 2-s2.0-33646378403 10.1111/j.1365-2826.2006.01429.x
84. Holsboer-Trachsler E., Stohler R., Hatzinger M., Repeated administration of the combined dexamethasone-human corticotropin releasing hormone stimulation test during treatment of depression. Psychiatry Research 1991 38 2 163 171 2-s2.0-0025773675 10.1016/0165-1781(91)90041-M
85. Carvalho L. A., Pariante C. M., In vitro modulation of the glucocorticoid receptor by antidepressants. Stress 2008 11 6 411 424 2-s2.0-57349143222 10.1080/10253890701850759
86. Zunszain P. A., Anacker C., Cattaneo A., Carvalho L. A., Pariante C. M., Glucocorticoids, cytokines and brain abnormalities in depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2011 35 3 722 729 2-s2.0-79954612444 10.1016/j.pnpbp.2010.04.011
87. Pace T. W. W., Hu F., Miller A. H., Activation of cAMP-protein kinase A abrogates STAT5-mediated inhibition of glucocorticoid receptor signaling by interferon-alpha. Brain, Behavior, and Immunity 2011 25 8 1716 1724 2-s2.0-80053893240 10.1016/j.bbi.2011.07.227
88. Anisman H., Gibb J., Hayley S., Influence of continuous infusion of interleukin-1 β on depression-related processes in mice: corticosterone, circulating cytokines, brain monoamines, and cytokine mRNA expression. Psychopharmacology 2008 199 2 231 244 2-s2.0-46649095394 10.1007/s00213-008- 1166-z
89. Reimold M., Knobel A., Rapp M. A., Batra A., Wiedemann K., Ströhle A., Zimmer A., Schönknecht P., Smolka M. N., Weinberger D. R., Goldman D., Machulla H., Bares R., Heinz A., Central serotonin transporter levels are associated with stress hormone response and anxiety. Psychopharmacology 2011 213 2-3 563 572 2-s2.0-79952487191 10.1007/s00213-010-1903-y
90. McEwen B. S., Glucocorticoids, depression, and mood disorders: structural remodeling in the brain. Metabolism 2005 54 5 20 23 2-s2.0-17444413709 10.1016/j.metabol.2005.01.008
91. Eisch A. J., Petrik D., Depression and hippocampal neurogenesis: a road to remission? Science 2012 338 6103 72 75 10.1126/science.1222941
92. Wang S., Zhang Z., Guo Y., Teng G., Chen B., Hippocampal neurogenesis and behavioural studies on adult ischemic rat response to chronic mild stress. Behavioural Brain Research 2008 189 1 9 16 2-s2.0-40849130816 10.1016/j.bbr.2007.11.028
93. Schoenfeld T. J., Gould E., Stress, stress hormones, and adult neurogenesis. Experimental Neurology 2012 233 1 12 21 2-s2.0-84856190425 10.1016/j.expneurol.2011.01.008
94. Eyre H., Baune B. T., Neuroplastic changes in depression: a role for the immune system. Psychoneuroendocrinology 2012 37 9 1397 1416 2-s2.0-84859840856 10.1016/j.psyneuen.2012.03.019
95. Seguin J. A., Brennan J., Mangano E., Hayley S., Proinflammatory cytokines differentially influence adult hippocampal cell proliferation depending upon the route and chronicity of administration. Neuropsychiatric Disease and Treatment 2009 5 1 5 14 2-s2.0-70449726615
96. Masi G., Brovedani P., The hippocampus, neurotrophic factors and depression: possible implications for the pharmacotherapy of depression. CNS Drugs 2011 25 11 913 931 2-s2.0-80555140031 10.2165/11595900-000000000-00000
97. Yang L., Zhang Z., Sun D., Xu Z., Yuan Y., Zhang X., Li N., Low serum BDNF may indicate the development of PSD in patients with acute ischemic stroke. International Journal of Geriatric Psychiatry 2011 26 5 495 502 2-s2.0-79953237009 10.1002/gps.2552
98. Zhou Z., Lu T., Xu G., Yue X., Zhu W., Ma M., Liu W., Zhu S., Liu X., Decreased serum Brain-Derived Neurotrophic Factor (BDNF) is associated with post-stroke depression but not with BDNF gene Val66Met polymorphism. Clinical Chemistry and Laboratory Medicine 2011 49 2 185 189 2-s2.0-79952094919 10.1515/CCLM.2011.039
99. You Z., Luo C., Zhang W., Chen Y., He J., Zhao Q., Zuo R., Wu Y., Pro- and anti-inflammatory cytokines expression in rat's brain and spleen exposed to chronic mild stress: involvement in depression. Behavioural Brain Research 2011 225 1 135 141 2-s2.0-79960884919 10.1016/j.bbr.2011.07.006
100. Numakawa T., Yokomaku D., Richards M., Hori H., Adachi N., Kunugi H., Functional interactions between steroid hormones and neurotrophin BDNF. World Journal of Biological Chemistry 2010 1 5 133 143 10.4331/wjbc.v1.i5.133
101. Hama S., Yamashita H., Yamawaki S., Kurisu K., Post-stroke depression and apathy: interactions between functional recovery, lesion location, and emotional response. Psychogeriatrics 2011 11 1 68 76 2-s2.0-79953134212 10.1111/j.1479-8301.2011.00358.x